Table 5. Distribution of antiviral resistance mutations.
No mutation | Resistance mutations | ||||||
Count | Mean | Median | Count | Mean | Median | ||
Region | North | 111 | – | – | 6 | – | – |
South | 27 | – | – | 2 | – | – | |
Gender | F | 40 | – | – | 3 | – | – |
M | 98 | – | – | 5 | – | – | |
Age | 138 | 37 | 33 | 8 | 37 | 34 | |
HBeAg | ND | 2 | – | – | 0 | – | – |
Neg | 69 | – | – | 2 | – | – | |
Pos | 67 | – | – | 6 | – | – | |
Anti-HBe* | ND | 2 | – | – | 0 | – | – |
Neg | 69 | – | – | 7 | – | – | |
Pos | 67 | – | – | 1 | – | – | |
Genotype | A | 28 | – | – | 2 | – | – |
C | 2 | – | – | 0 | – | – | |
D | 107 | – | – | 6 | – | – | |
E | 1 | – | – | 0 | – | – | |
Viral loada | 138 | 4,50 | 4,43 | 8 | 5,44 | 5,90 |
*denotes p<0.05; aValues are given as log10 international units (IU)/ml; ND: Not done; F = female, M = male.